Vienna

As a central pillar of the European biotechnology sector, Vienna is home to the renowned Vienna BioCenter, where over 2,000 scientists drive breakthroughs in molecular biology and biomedical research.

Global pharmaceutical leaders like Boehringer Ingelheim and Takeda maintain a massive presence here, leveraging Vienna's sophisticated infrastructure for both large-scale production and high-stakes R&D.

The ecosystem is equally vibrant in the medical device and medtech industries, where specialized startups utilize AI-driven diagnostics and digital health platforms to transform patient care.

Academic excellence is anchored by the Medical University of Vienna, one of the largest and most cited research institutions in the German-speaking world.

Through the LISAvienna platform, the city fosters a seamless tech transfer environment, connecting ambitious startups with venture capital and strategic industry partners.

Vienna’s commitment to clinical research and precision medicine is supported by a robust network of world-ranked hospitals and state-of-the-art laboratory facilities.

This collaborative spirit ensures that innovation in drug research and bioprocessing moves rapidly from the lab bench to the global market.

Ultimately, Vienna's unique combination of high quality of life and intensive research funding makes it a magnet for top-tier international talent and life science investment.